Pre-eclampsia and eclampsia: An update on the pharmacological treatment applied in Portugal
GM Peres, M Mariana, E Cairrão - Journal of cardiovascular development …, 2018 - mdpi.com
Pre-eclampsia and eclampsia are two hypertensive disorders of pregnancy, considered
major causes of maternal and perinatal death worldwide. Pre-eclampsia is a multisystemic …
major causes of maternal and perinatal death worldwide. Pre-eclampsia is a multisystemic …
Pathophysiology and current clinical management of preeclampsia
LM Amaral, K Wallace, M Owens, B LaMarca - Current hypertension …, 2017 - Springer
Preeclampsia is characterized by blood pressure greater than 140/90 mmHg in the second
half of pregnancy. This disease is a major contributor to preterm and low birth weight babies …
half of pregnancy. This disease is a major contributor to preterm and low birth weight babies …
[PDF][PDF] Evidence-based management for preeclampsia
P von Dadelszen, J Menzies, S Gilgoff, F Xie… - Front …, 2007 - article.imrpress.com
Introduction 3. Indications for outpatient assessment and office management 4. Indications to
consider hospitalization 4.1. Indications for conservative hospital management 4.2 …
consider hospitalization 4.1. Indications for conservative hospital management 4.2 …
Severe pre-eclampsia and hypertensive crises
N Arulkumaran, L Lightstone - Best Practice & Research Clinical Obstetrics …, 2013 - Elsevier
Hypertensive disorders of pregnancy are one of the leading causes of peripartum morbidity
and mortality globally. Hypertensive disease in pregnancy is associated with a spectrum of …
and mortality globally. Hypertensive disease in pregnancy is associated with a spectrum of …
Oral nifedipine vs. intravenous labetalol for treatment of pregnancy‐induced severe pre‐eclampsia
DD Shi, FZ Yang, L Zhou… - Journal of clinical …, 2016 - Wiley Online Library
What is known and objective Pre‐eclampsia is one of the most challenging diseases of
pregnancy. Both nifedipine and labetalol have been used for treatment of pregnancy …
pregnancy. Both nifedipine and labetalol have been used for treatment of pregnancy …
Treatment of preeclampsia: current approach and future perspectives
E Berzan, R Doyle, CM Brown - Current hypertension reports, 2014 - Springer
Hypertension is the most common medical disorder encountered during pregnancy,
occurring in about 6–8% of pregnancies. Preeclampsia is a pregnancy-specific disorder that …
occurring in about 6–8% of pregnancies. Preeclampsia is a pregnancy-specific disorder that …
Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring
R Fox, J Kitt, P Leeson, CYL Aye… - Journal of clinical …, 2019 - mdpi.com
Hypertensive disorders of pregnancy affect up to 10% of pregnancies worldwide, which
includes the 3%–5% of all pregnancies complicated by preeclampsia. Preeclampsia is …
includes the 3%–5% of all pregnancies complicated by preeclampsia. Preeclampsia is …
Preeclampsia emerging as a novel risk factor for cardiovascular disease in the offspring
AA Karatza, G Dimitriou - Current pediatric reviews, 2020 - ingentaconnect.com
Introduction: Preeclampsia is a pregnancy specific disorder which affects 2%-8% of all
gestations and is associated with high maternal, fetal and neonatal morbidity and mortality …
gestations and is associated with high maternal, fetal and neonatal morbidity and mortality …
Pre-eclampsia
Pre-eclampsia is a life-threatening disease of pregnancy unique to humans and a leading
cause of maternal and neonatal morbidity and mortality. Women who survive pre-eclampsia …
cause of maternal and neonatal morbidity and mortality. Women who survive pre-eclampsia …
Preeclampsia-current management and future approach
W Dymara-Konopka, M Laskowska… - Current …, 2018 - ingentaconnect.com
Preeclampsia is one of the most serious pregnancy-specific medical conditions of increasing
incidence. It remains a major cause of maternal and fetal morbidity and mortality. Although …
incidence. It remains a major cause of maternal and fetal morbidity and mortality. Although …